Novo Nordisk spends big in France to expand obesity drug capacity

by

Danish pharmaceutical giant Novo Nordisk on Thursday announced a major investment in a French production site to expand capacity including for a blockbuster anti-obesity drug.

Leave A Comment

Your email address will not be published. Required fields are marked *